Response to Carboplatin and Paclitaxel in the treatment of hereditary breast ovarian cancer syndrome (HBOC): a case report

被引：0
|
作者：
Mehmood, Faisal [1 ]
Touseef, Mumtaz [2 ]
Ashraf, Amna [2 ]
Rai, Izza Ali [3 ]
机构：
[1] Combined Mil Hosp, Dept Radiol, Lahore, Pakistan
[2] Combined Mil Hosp, Dept Med, Lahore, Pakistan
[3] Combined Mil Hosp, Dept Vasc Surg, Lahore, Pakistan
来源：
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION | 2024年 / 74卷 / 12期
关键词：
Hereditary breast ovarian cancer; Breast cancer; Ovarian cancer; HBOC; BRCA; PALB2; Chemotherapy; Carboplatin; Paclitaxel; PREVALENCE; MUTATIONS;
D O I：
10.47391/JPMA.20059
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The co-occurrence of primary breast cancer and primary ovarian cancer is an exceptional hereditary phenomenon and results from inherent mutations in critical genes like a unique case of hereditary breast-ovarian cancer syndrome (HBOC) reported in Combined Military Hospital, Lahore, Pakistan. It was marked by pathogenic variants in RAD51D, PALB2, CHEK1, and TP53 genes. Remarkably, the patient exhibited an outstanding response to the chemotherapy agents, Carboplatin and Paclitaxel. This dynamic treatment not only led to nearly complete remission of high-grade ovarian serous cancer but also triggered regression in grade-2 invasive ductal breast cancer after just a few rounds of chemotherapy. Consequently, what started as palliative care evolved into a curative triumph.
引用
收藏
页码：2184 / 2187
页数：4
相关论文
共 50 条
  • [11] Response to paclitaxel and carboplatin in metastatic salivary gland cancer: A case report
    Ruzich, JC
    Ciesla, MC
    Clark, JI
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (04): : 406 - 410
  • [12] CARBOPLATIN AND PACLITAXEL (TAXOL(R)) FOR THE TREATMENT OF ADVANCED OVARIAN-CANCER
    OZOLS, RF
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1994, 4 : 13 - 17
  • [13] Comparison of Efficacies of Dose Dense Paclitaxel Plus Carboplatin and Conventional Paclitaxel Plus Carboplatin in the Treatment of Epithelial Ovarian Cancer
    Sunar, Veli
    Korkmaz, Vakkas
    Aslan, Koray
    Kose, Caner
    Sarici, Furkan
    Arik, Zafer
    Meydanli, Mehmet Mutlu
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2021, 31 (04): : 239 - 245
  • [14] Pharmacokinetics of paclitaxel and carboplatin in a hemodialysis patient with advanced ovarian cancer
    Yoshida, H.
    Sumi, T.
    Abe, K.
    Ishiko, O.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2009, 30 (05) : 583 - 585
  • [15] Hereditary Breast-Ovarian Cancer Syndrome in Russia
    Sokolenko, A. P.
    Iyevleva, A. G.
    Mitiushkina, N. V.
    Suspitsin, E. N.
    Preobrazhenskaya, E. V.
    Kuligina, E. Sh.
    Voskresenskiy, D. A.
    Lobeiko, O. S.
    Krylova, N. Yu.
    Gorodnova, T. V.
    Buslov, K. G.
    Bit-Sava, E. M.
    Dolmatov, G. D.
    Porhanova, N. V.
    Polyakov, I. S.
    Abysheva, S. N.
    Katanugina, A. S.
    Baholdin, D. V.
    Yanus, G. A.
    Togo, A. V.
    Moiseyenko, V. M.
    Maximov, S. Ya.
    Semiglazov, V. F.
    Imyanitov, E. N.
    ACTA NATURAE, 2010, 2 (04): : 31 - 35
  • [16] Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing
    Tuncer, Seref Bugra
    Celik, Betul
    Erciyas, Seda Kilic
    Erdogan, Ozge Sukruoglu
    Gultaslar, Busra Kurt
    Odemis, Demet Akdeniz
    Avsar, Mukaddes
    Sen, Fatma
    Saip, Pinar Mualla
    Yazici, Hulya
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 254
  • [17] A case of simultaneous breast cancer and ovarian cancer based on a hereditary breast and ovarian cancer syndrome
    Kotaka, Saki
    Yasui, Hiroaki
    Tsubouchi, Hirofumi
    Mori, Masahiko
    Kotani, Haruru
    Yoshimura, Akiyo
    Ouchi, Akira
    Okuno, Masataka
    Komori, Koji
    Shimizu, Yasuhiro
    Suzuki, Shiro
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2023, 85 (04): : 814 - 821
  • [18] Combination treatment with paclitaxel, carboplatin and cetuximab in maxillary sinus cancer: A case report
    Morimoto, Masahiro
    Takano, Masashi
    Sato, Takehiko
    Makino, Shujiroh
    ONCOLOGY LETTERS, 2024, 27 (03)
  • [19] Olaparib and paclitaxel in combination with carboplatin in treatment of ovarian cancer: influence on disease control
    Zhang, Heling
    Zhang, Ye
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (01): : 468 - 475
  • [20] Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe
    Marmolejo, David Humberto
    Wong, Mark Yu Zheng
    Bajalica-Lagercrantz, Svetlana
    Tischkowitz, Marc
    Balmana, Judith
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2021, 64 (12)
12345